Drug interactions
Gemtuzumab + Indacaterol
Severity: Moderate
Gemtuzumab and Indacaterol: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Gemtuzumab ozogamicin has been associated with QT prolongation, and beta-agonists can add to QT effects and lower potassium. The combination may raise the risk of ventricular arrhythmia in patients with other risk factors.
What this interaction means in plain words
Gemtuzumab and Indacaterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive effects on cardiac repolarization, with beta-agonist-induced hypokalemia as a possible contributor.
What to do
Monitor ECG and correct potassium and magnesium before and during treatment. Reassess the need for indacaterol if QT prolongation develops.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Gemtuzumab and Indacaterol, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Indacaterol
Frequently asked questions
Can I take Gemtuzumab with Indacaterol?
MediHelp rates the interaction as moderate. Gemtuzumab and Indacaterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Gemtuzumab ozogamicin has been associated with QT prolongation, and beta-agonists can add to QT effects and lower potassium. The combination may raise the risk of ventricular arrhythmia in patients with other risk factors.
How serious is the interaction between Gemtuzumab and Indacaterol?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and correct potassium and magnesium before and during treatment. Reassess the need for indacaterol if QT prolongation develops.
What other medicines interact with Indacaterol?
MediHelp also lists interactions of Indacaterol with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Indacaterol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
